On February 4, 2014, the Federal Trade Commission (“FTC”) hosted a day-long public workshop on “Follow-on Biologics: Impact of Recent Legislative and Regulatory Naming Proposals on Competition” to discuss the potential impact of state regulations and naming conventions on competition involving biologic medicines and follow-on biosimilar drugs. The workshop reflects the FTC’s renewed interest in
More Posts
Medical experts cast doubt on multivitamin health benefits
Legal Update: Online sales of counterfeit sports apparel
It’s a counterfeit holiday time of year
"Humane” producers of foie gras unable to duck false advertising claims
Hybrid Fuel Efficiency Claims Targeted in Class-Action Lawsuit
Fifth Circuit Cites Laches as Properly Barring Recovery of Monetary Damages in Trademark Infringement Suit
FDA Targets Cosmeceutical Marketing Claims
Recent Decisions Confirm that “All Natural” Food Labels Are Not Warranties
FDA to study “composite scores” in DTC ads
Subscribe: Subscribe via RSS
Firm/Org